These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 23350368

  • 1. [LOH and genetic polymorphysms of breast cancer].
    Utsumi T.
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():71-5. PubMed ID: 23350368
    [No Abstract] [Full Text] [Related]

  • 2. [Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system].
    Berstein LM, Zimarina TS, Tsyrlina EV, Kovalevskiĭ AIu, Imianitov EN.
    Vopr Onkol; 2004 Sep; 50(2):169-73. PubMed ID: 15176218
    [Abstract] [Full Text] [Related]

  • 3. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
    Yuan X, Zhou G, Zhai Y, Xie W, Cui Y, Cao J, Zhi L, Zhang H, Yang H, Zhang X, Qiu W, Peng Y, Zhang X, Yu L, Xia X, He F.
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
    Miyoshi Y, Noguchi S.
    Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391
    [Abstract] [Full Text] [Related]

  • 5. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
    Ferlin A, Ganz F, Pengo M, Selice R, Frigo AC, Foresta C.
    Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
    [Abstract] [Full Text] [Related]

  • 6. Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes.
    Berstein L, Zimarina T, Imyanitov E, Kovalevskij A, Maximov S, Pujol P, Thijssen J.
    Maturitas; 2006 Jul 20; 54(4):352-5. PubMed ID: 16730930
    [Abstract] [Full Text] [Related]

  • 7. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
    Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ, McTiernan A.
    Cancer Epidemiol Biomarkers Prev; 2004 Jan 20; 13(1):94-101. PubMed ID: 14744739
    [Abstract] [Full Text] [Related]

  • 8. Variability in estrogen-metabolizing genes and their association with genomic instability in untreated breast cancer patients and healthy women.
    dos Santos RA, Teixeira AC, Mayorano MB, Carrara HH, de Andrade J, Takahashi CS.
    J Biomed Biotechnol; 2011 Jan 20; 2011():571784. PubMed ID: 21716904
    [Abstract] [Full Text] [Related]

  • 9. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B, Ahmed S, Inzunza J, Matthews J.
    Mol Cancer Res; 2009 Jun 20; 7(6):977-86. PubMed ID: 19470599
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms in steroid hormone pathway genes and mammographic density.
    Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C.
    Breast Cancer Res Treat; 2003 Jan 20; 77(1):27-36. PubMed ID: 12602902
    [Abstract] [Full Text] [Related]

  • 11. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
    Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY.
    Cancer Res; 1999 Oct 01; 59(19):4870-5. PubMed ID: 10519398
    [Abstract] [Full Text] [Related]

  • 12. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
    Greenlee H, Chen Y, Kabat GC, Wang Q, Kibriya MG, Gurvich I, Sepkovic DW, Bradlow HL, Senie RT, Santella RM, Ahsan H.
    Breast Cancer Res Treat; 2007 Mar 01; 102(1):111-7. PubMed ID: 16850246
    [Abstract] [Full Text] [Related]

  • 13. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
    Saintot M, Malaveille C, Hautefeuille A, Gerber M.
    Int J Cancer; 2003 Nov 20; 107(4):652-7. PubMed ID: 14520706
    [Abstract] [Full Text] [Related]

  • 14. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism.
    Mitrunen K, Hirvonen A.
    Mutat Res; 2003 Sep 20; 544(1):9-41. PubMed ID: 12888106
    [Abstract] [Full Text] [Related]

  • 15. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.
    Fu J, Weise AM, Falany JL, Falany CN, Thibodeau BJ, Miller FR, Kocarek TA, Runge-Morris M.
    Breast Cancer Res Treat; 2010 Feb 20; 120(1):35-45. PubMed ID: 19308726
    [Abstract] [Full Text] [Related]

  • 16. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.
    Cussenot O, Azzouzi AR, Nicolaiew N, Fromont G, Mangin P, Cormier L, Fournier G, Valeri A, Larre S, Thibault F, Giordanella JP, Pouchard M, Zheng Y, Hamdy FC, Cox A, Cancel-Tassin G.
    J Clin Oncol; 2007 Aug 20; 25(24):3596-602. PubMed ID: 17704407
    [Abstract] [Full Text] [Related]

  • 17. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
    Kocabaş NA, Sardaş S, Cholerton S, Daly AK, Karakaya AE.
    Arch Toxicol; 2002 Nov 20; 76(11):643-9. PubMed ID: 12415427
    [Abstract] [Full Text] [Related]

  • 18. Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders.
    Huber JC, Schneeberger C, Tempfer CB.
    Maturitas; 2002 May 20; 42(1):1-12. PubMed ID: 12020974
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women.
    Martínez-Ramírez OC, Pérez-Morales R, Castro C, Flores-Díaz A, Soto-Cruz KE, Astorga-Ramos A, Gonsebatt ME, Casas L, Valdés-Flores M, Rubio J.
    Breast; 2013 Jun 20; 22(3):335-43. PubMed ID: 23000097
    [Abstract] [Full Text] [Related]

  • 20. Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.
    Syamala VS, Syamala V, Sheeja VR, Kuttan R, Balakrishnan R, Ankathil R.
    Cancer Invest; 2010 Mar 20; 28(3):304-11. PubMed ID: 19863350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.